Home Biotechnology Biosimilar Monoclonal Antibodies Market Size, Demand | Industry Report 2033

Biosimilar Monoclonal Antibodies Market Size & Outlook, 2025-2033

Biosimilar Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Type  (Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others), By Indication  (Oncology, Autoimmune diseases, Others), By Distribution Channel  (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI56962DR
Last Updated : Jul, 2025
Pages : 110
Author : Dhanashri Bhapakar
Format : PDF, Excel

Market Segmentation

  1. Biosimilar Monoclonal Antibodies Market, By Type  (2021-2033)
    1. Adalimumab
    2. Bevacizumab
    3. Infliximab
    4. Rituximab
    5. Trastuzumab
    6. Others
  2. Biosimilar Monoclonal Antibodies Market, By Indication  (2021-2033)
    1. Oncology
    2. Autoimmune diseases
    3. Others
  3. Biosimilar Monoclonal Antibodies Market, By Distribution Channel  (2021-2033)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Others
    1. North America
      1. North America Biosimilar Monoclonal Antibodies Market, By Type 
        1. Adalimumab
          1. Bevacizumab
            1. Infliximab
              1. Rituximab
                1. Trastuzumab
                  1. Others
                  2. North America Biosimilar Monoclonal Antibodies Market, By Indication 
                    1. Oncology
                      1. Autoimmune diseases
                        1. Others
                        2. North America Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                          1. Hospital Pharmacies
                            1. Drug Stores & Retail Pharmacies
                              1. Others
                              2. U.S.
                                1. U.S. Biosimilar Monoclonal Antibodies Market, By Type 
                                  1. Adalimumab
                                    1. Bevacizumab
                                      1. Infliximab
                                        1. Rituximab
                                          1. Trastuzumab
                                            1. Others
                                            2. U.S. Biosimilar Monoclonal Antibodies Market, By Indication 
                                              1. Oncology
                                                1. Autoimmune diseases
                                                  1. Others
                                                  2. U.S. Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                    1. Hospital Pharmacies
                                                      1. Drug Stores & Retail Pharmacies
                                                        1. Others
                                                      2. Canada
                                                    2. Europe
                                                      1. Europe Biosimilar Monoclonal Antibodies Market, By Type 
                                                        1. Adalimumab
                                                          1. Bevacizumab
                                                            1. Infliximab
                                                              1. Rituximab
                                                                1. Trastuzumab
                                                                  1. Others
                                                                  2. Europe Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                    1. Oncology
                                                                      1. Autoimmune diseases
                                                                        1. Others
                                                                        2. Europe Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                          1. Hospital Pharmacies
                                                                            1. Drug Stores & Retail Pharmacies
                                                                              1. Others
                                                                              2. U.K.
                                                                                1. U.K. Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                  1. Adalimumab
                                                                                    1. Bevacizumab
                                                                                      1. Infliximab
                                                                                        1. Rituximab
                                                                                          1. Trastuzumab
                                                                                            1. Others
                                                                                            2. U.K. Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                              1. Oncology
                                                                                                1. Autoimmune diseases
                                                                                                  1. Others
                                                                                                  2. U.K. Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                    1. Hospital Pharmacies
                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                        1. Others
                                                                                                      2. Germany
                                                                                                      3. France
                                                                                                      4. Spain
                                                                                                      5. Italy
                                                                                                      6. Russia
                                                                                                      7. Nordic
                                                                                                      8. Benelux
                                                                                                      9. Rest of Europe
                                                                                                    2. APAC
                                                                                                      1. APAC Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                        1. Adalimumab
                                                                                                          1. Bevacizumab
                                                                                                            1. Infliximab
                                                                                                              1. Rituximab
                                                                                                                1. Trastuzumab
                                                                                                                  1. Others
                                                                                                                  2. APAC Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                    1. Oncology
                                                                                                                      1. Autoimmune diseases
                                                                                                                        1. Others
                                                                                                                        2. APAC Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                          1. Hospital Pharmacies
                                                                                                                            1. Drug Stores & Retail Pharmacies
                                                                                                                              1. Others
                                                                                                                              2. China
                                                                                                                                1. China Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                                                  1. Adalimumab
                                                                                                                                    1. Bevacizumab
                                                                                                                                      1. Infliximab
                                                                                                                                        1. Rituximab
                                                                                                                                          1. Trastuzumab
                                                                                                                                            1. Others
                                                                                                                                            2. China Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                                              1. Oncology
                                                                                                                                                1. Autoimmune diseases
                                                                                                                                                  1. Others
                                                                                                                                                  2. China Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                        1. Others
                                                                                                                                                      2. Korea
                                                                                                                                                      3. Japan
                                                                                                                                                      4. India
                                                                                                                                                      5. Australia
                                                                                                                                                      6. Taiwan
                                                                                                                                                      7. South East Asia
                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                      1. Middle East and Africa Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                                                                        1. Adalimumab
                                                                                                                                                          1. Bevacizumab
                                                                                                                                                            1. Infliximab
                                                                                                                                                              1. Rituximab
                                                                                                                                                                1. Trastuzumab
                                                                                                                                                                  1. Others
                                                                                                                                                                  2. Middle East and Africa Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                                                                    1. Oncology
                                                                                                                                                                      1. Autoimmune diseases
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. Middle East and Africa Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                                                            1. Drug Stores & Retail Pharmacies
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. UAE
                                                                                                                                                                                1. UAE Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                                                                                                  1. Adalimumab
                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                      1. Infliximab
                                                                                                                                                                                        1. Rituximab
                                                                                                                                                                                          1. Trastuzumab
                                                                                                                                                                                            1. Others
                                                                                                                                                                                            2. UAE Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                                                                                              1. Oncology
                                                                                                                                                                                                1. Autoimmune diseases
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. UAE Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                      1. LATAM Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                                                                                                                        1. Adalimumab
                                                                                                                                                                                                          1. Bevacizumab
                                                                                                                                                                                                            1. Infliximab
                                                                                                                                                                                                              1. Rituximab
                                                                                                                                                                                                                1. Trastuzumab
                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                  2. LATAM Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                                                                                                                    1. Oncology
                                                                                                                                                                                                                      1. Autoimmune diseases
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. LATAM Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                                                                                                            1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                              2. Brazil
                                                                                                                                                                                                                                1. Brazil Biosimilar Monoclonal Antibodies Market, By Type 
                                                                                                                                                                                                                                  1. Adalimumab
                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                      1. Infliximab
                                                                                                                                                                                                                                        1. Rituximab
                                                                                                                                                                                                                                          1. Trastuzumab
                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                            2. Brazil Biosimilar Monoclonal Antibodies Market, By Indication 
                                                                                                                                                                                                                                              1. Oncology
                                                                                                                                                                                                                                                1. Autoimmune diseases
                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                  2. Brazil Biosimilar Monoclonal Antibodies Market, By Distribution Channel 
                                                                                                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                                                                                                      1. Drug Stores & Retail Pharmacies
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                  Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                  Get This Report

                                                                                                                                                                                                                                                  Download Free Sample

                                                                                                                                                                                                                                                  Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                  The button will be active once the above form is filled

                                                                                                                                                                                                                                                  Our Clients:

                                                                                                                                                                                                                                                  LG Electronics
                                                                                                                                                                                                                                                  AMCAD Engineering
                                                                                                                                                                                                                                                  KOBE STEEL LTD.
                                                                                                                                                                                                                                                  Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                  Voith Group
                                                                                                                                                                                                                                                  International Paper
                                                                                                                                                                                                                                                  Hansol Paper
                                                                                                                                                                                                                                                  Whirlpool Corporation
                                                                                                                                                                                                                                                  Sony
                                                                                                                                                                                                                                                  Samsung Electronics
                                                                                                                                                                                                                                                  Qualcomm
                                                                                                                                                                                                                                                  Google
                                                                                                                                                                                                                                                  Fiserv
                                                                                                                                                                                                                                                  Veto-Pharma
                                                                                                                                                                                                                                                  Nippon Becton Dickinson
                                                                                                                                                                                                                                                  Merck
                                                                                                                                                                                                                                                  Argon Medical Devices
                                                                                                                                                                                                                                                  Abbott
                                                                                                                                                                                                                                                  Ajinomoto
                                                                                                                                                                                                                                                  Denon
                                                                                                                                                                                                                                                  Doosan
                                                                                                                                                                                                                                                  Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                  LG Chemicals
                                                                                                                                                                                                                                                  LCY chemical group
                                                                                                                                                                                                                                                  Bayer
                                                                                                                                                                                                                                                  Airrane
                                                                                                                                                                                                                                                  BASF
                                                                                                                                                                                                                                                  Toyota Industries
                                                                                                                                                                                                                                                  Nissan Motors
                                                                                                                                                                                                                                                  Neenah
                                                                                                                                                                                                                                                  Mitsubishi
                                                                                                                                                                                                                                                  Hyundai Motor Company

                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                  Address:
                                                                                                                                                                                                                                                  Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                  Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                  Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                  Contact Us:
                                                                                                                                                                                                                                                  +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                  +91 8087085354 (India)
                                                                                                                                                                                                                                                  +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                  sales@straitsresearch.com

                                                                                                                                                                                                                                                  Quick Links
                                                                                                                                                                                                                                                  Help
                                                                                                                                                                                                                                                  Verified. Protected. Secure.
                                                                                                                                                                                                                                                  DMCA.com Protection Status
                                                                                                                                                                                                                                                  Secure Payments:
                                                                                                                                                                                                                                                  Follow Us:
                                                                                                                                                                                                                                                  www.straitsresearch.com © Copyright . All rights Reserved.